P. M. A. Calverley (Liverpool, United Kingdom), L. Puente Maestu (Madrid, Spain)
Self-reported cardiovascular disease and exercise performance in stable COPD
P. Calverley, R. Tal-Singer, L. Edwards, M. Watkins, M. Spruit, E. Wouters, J. Vestbo (Liverpool, United Kingdom; Raleigh, United States Of America; Maastricht, Netherlands; Copenhagen, Denmark)
|  |
Chronotropic incompetence during maximal cardiopulmonary exercise test in patients with COPD and CHF
K. Terziyski, B. Marinov, O. Aliman, S. Kostianev (Plovdiv, Bulgaria)
|   |
Clinical relevance of constant power exercise duration changes in COPD
L. Puente-Maestu, F. Villar, J. DeMiguel, W. W. Stringer, P. Sanz, M. L. Sanz, J. García de Pedro, Y. Martinez Abad (Madrid, Spain; Torrance, United States Of America)
| |
Acute bronchodilation improves the dynamics of oxygen delivery to and utilization by the skeletal muscles during exercise in advanced COPD
D. Berton, L. Takara, P. Figueiredo, A. C. Siqueira, M. Reis, L. Ferreira, G. Chiappa, L. Nery, J. A. Neder (Sao Paulo, Brazil; Lexington, United States Of America)
| |
Comparative effects of formoterol monotherapy versus formoterol plus tiotropium on dynamic hyperinflation and exercise tolerance in COPD
D. C. Berton, M. Reis, A. C. B. Siqueira, A. Barroco, L. Takara, D. Bravo, S. Andreoni, J. A. Neder (Sao Paulo, Brazil)
| |
Effect of treatment on peak oxygen uptake during incremental exercise in IPAH
D. Martolini, G. Valli, A. M. Ferrazza, C. Gambardella, B. Pizzuto, P. Marinelli, A. Fedeli, E. Angelici, C. D. Vizza, P. Palange (Rome, Italy)
| |
Budesonide/formoterol improves exercise tolerance compared with placebo and formoterol in COPD patients
H. Worth, K. Foerster, S. Peterson, U. Nihlen, H. Magnussen (Furth, Berlin, Grosshansdorf, Germany; Lund, Sweden)
| |
Effect of glutamine ingestion on aerobic function during exercise in stable severe COPD
S. Marwood, S. Jack, M. Patel, P. Walker, J. Bowtell, P. Calverley (Liverpool, London, United Kingdom)
| |